Earnings Call · Q2 FY2026·2026-08-06

Q2 26EPS +35.29%·Rev n/aQ1 26EPS -23.78%·Rev n/aQ4 25EPS 0.00%·Rev n/aQ3 25EPS +3.85%·Rev n/a⚠ consensus missing

IOVANCE BIOTHERAPEUTICS, INC. IOVA

Daniel — Conference Call Operator

Sara Pellegrino — Senior Vice President, Investor Relations and Corporate Communications

Dr. Fred Vogt — Interim CEO and President

Corleen Roche — Chief Financial Officer

spk02

+43.1%1d on move date3d+47.5%5d+55.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IOVA calls or request research access.

More IOVA calls Browse calls Request research access